Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction
- PMID: 17723076
- DOI: 10.1592/phco.27.9.1231
Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction
Abstract
Study objective: To determine the effect of S-albuterol on the dose response to levalbuterol in patients with moderate bronchoconstriction induced by a methacholine challenge.
Design: Prospective, randomized, double-blind, placebo-controlled, crossover study.
Setting: University-affiliated clinical trial center.
Patients: Twenty-two adults with mild, stable asthma.
Intervention: At the screening visit, patients were switched from their beta2-agonist to ipratropium bromide for use as an as-needed rescue therapy. At the baseline visit 2-6 days later, the provocative concentration of methacholine to induce a 30% decrease in forced expiratory volume in 1 second (FEV(1) PC(30)) was determined, followed by a nebulized racemic albuterol dose-response study with three doses of albuterol, to familiarize patients with the procedures. At visits 2 and 3, patients were randomly assigned to receive nebulized normal saline placebo or S-albuterol 5 mg before the methacholine challenge and were administered three escalating doses of levalbuterol after the challenge.
Measurements and main results: Area under the curve for FEV(1) over 40 minutes (AUC(0-40)) after administration of levalbuterol was the primary outcome, with slope of FEV(1) as the secondary outcome. In addition, the fraction of exhaled nitric oxide (FeNO) was measured before and after the challenges. In the 17 patients who met criteria for completion, no deleterious effect for S-albuterol was found for FEV(1) PC(30), AUC(0-40) FEV(1), or the FEV(1) slope(0-40). However, S-albuterol reduced the provocative concentration of methacholine to induce a 20% decrease in FEV(1) (PC(20) 0.52 +/- 2.06 vs 0.39 +/- 1.58 mg/ml, placebo vs S-albuterol, p=0.044) but did not affect FeNO.
Conclusion: A single high dose of S-albuterol did not alter the bronchodilator response to levalbuterol. The effect on bronchial responsiveness requires further study.
Similar articles
-
The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.Clin Ther. 2005 Jul;27(7):1004-12. doi: 10.1016/j.clinthera.2005.07.006. Clin Ther. 2005. PMID: 16154479 Clinical Trial.
-
Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.Curr Med Res Opin. 2006 Jun;22(6):1217-26. doi: 10.1185/030079906X112534. Curr Med Res Opin. 2006. PMID: 16846555 Clinical Trial.
-
Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.Pharmacotherapy. 2008 Mar;28(3):287-94. doi: 10.1592/phco.28.3.287. Pharmacotherapy. 2008. PMID: 18294107 Clinical Trial.
-
Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.Ann Allergy Asthma Immunol. 2003 Jun;90(6):583-91; quiz 591-2, 659. doi: 10.1016/S1081-1206(10)61859-5. Ann Allergy Asthma Immunol. 2003. PMID: 12839314 Review.
-
Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.J Am Osteopath Assoc. 2004 Jul;104(7):288-93. J Am Osteopath Assoc. 2004. PMID: 15293593 Review.
Cited by
-
Chiral Switch Drugs for Asthma and Allergies: True Benefit or Marketing Hype.Pediatr Allergy Immunol Pulmonol. 2013 Sep;26(3):157-160. doi: 10.1089/ped.2013.0285. Pediatr Allergy Immunol Pulmonol. 2013. PMID: 24066264 Free PMC article.
-
Detrimental effects of albuterol on airway responsiveness requires airway inflammation and is independent of β-receptor affinity in murine models of asthma.Respir Res. 2011 Mar 7;12(1):27. doi: 10.1186/1465-9921-12-27. Respir Res. 2011. PMID: 21385381 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous